MRE-269
| CAS No. | 475085-57-5 | Cat. No. | BCP16833 |
| Name | MRE-269 | ||
| Synonyms | MRE269;MRE 269;ACT 333679;ACT-333679;ACT333679; | ||
| Formula | C25H29N3O3 | M. Wt | 419.52 |
| Description | MRE-269, also known as ACT-333679, is a long-acting and highly selective prostacyclin receptor agonist. MRE-269, the active form or metabolite of Selexipag (NS-304), is much more selective for the IP receptor than are the prostacyclin analogs beraprost and iloprost, which also have high affinity for the EP(3) receptor. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Prostaglandin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.